DEADLINE: 22 September 2023
HSE has received several applications for authorisation for the following substances/uses and has announced public consultations for each of these applications. Details can be viewed below:
-
Reference: AFA046-01
Application type: Initial
Substances: Chromium trioxide
Use: Use of chromium trioxide for functional chrome plating of aircraft components for civil & military sectors that meet the airworthiness requirements and hydraulic components for military vehicles.
View the details
-
Reference: AFA048-01
Application type: Initial
Substance: Chromium trioxide
Use: Use of chromium trioxide for the surface treatment of engineering components, mainly for the aerospace and defence sector, with the purpose of creating a coating to meet specific and critical performance characteristics.
View the details
-
Reference: AFA049-01
Application type: Initial
Substance: Chromium trioxide
Use: Use of chromium trioxide for the hard (functional/engineering) chromium electroplating of engineering components with the purpose of creating a coating to meet specific performance characteristics.
View the details
-
Reference: AFA050-01
Application type: Initial
Substances: Chromium trioxide
Use: Use of chromium trioxide for the hard (functional/engineering) chromium electroplating of engineering components as part of an in-house production facility with the purpose of creating a coating to meet specific performance characteristics.
View the details
-
Reference: AFA051-01
Application type: Initial
Substances: Chromium trioxide
Use: Use of chromium trioxide for the surface treatment of engineering components, mainly for the aerospace and defence sector, with the purpose of creating a coating to meet specific and critical performance characteristics.
View the details
Article 64 in the UK REACH Regulation makes provisions for HSE to obtain and use additional information on possible alternatives or technologies as part of the opinion forming process.
Any third parties with an interest in these applications are strongly encouraged to share any relevant information.
Scientific and technical information on possible alternatives or technologies should be submitted directly to HSE using the commenting webform and templates by 22 September 2023.
Non-confidential comments will be published on HSE’s website.
Details of the adopted opinions, granted UK REACH authorisations and in-progress applications can be found on the HSE website.
The Secretary of State for the Department for Environment, Food and Rural Affairs (Defra), with the consent of Scottish and Welsh Ministers, has made a decision on two applications for authorisation for the time-limited use of substances of very high concern (SVHC) under UK REACH.
The Defra Secretary of State has granted authorisations to:
- Abbott Laboratories Ltd for the use of 4-(1,1,3,3-tetramethylbutyl) phenol, ethoxylated (‘4-tert-OPnEO’) as a surfactant in the final use of 'in-vitro' Diagnostic Devices (IVDs) for clinical testing in ARCHITECT, Alinity and ABBOTT PRISM automated analyser systems; and
- IDEXX Laboratories Ltd for the use of 4-(1,1,3,3-Tetramethylbutyl)phenol, ethoxylated (4-tert-OPnEO) and use of 4-Nonylphenol, branched and linear, ethoxylated (4-NPnEO) in in-vitro diagnostic veterinary products (SNAP tests and ELISA Plate tests) as an ingredient in the wash solutions, sample diluents, control solutions, conjugate solutions, SNAP wash solutions, tissue soaking buffers and detection solutions.
Applications for authorisation received by the HSE, and the opinions on these, are included in the HSE database of applications granted and in progress.
Decisions made by the Defra Secretary of State are published on GOV.UK.
If you have any questions relating to this ebulletin, please contact us.
|
